
|Articles|April 1, 2004
Academy needs you for exciting new project
The American Academy of Ophthalmology (AAO) is busy planning an exciting national publicity campaign to promote eye injury awareness and prevention to the public. But it still needs one thing-you!
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
4
Phase 1 trial findings confirm safety and tolerability of Huons’ dry eye therapy
5















































.png)


